Cargando…
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients wi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152511/ https://www.ncbi.nlm.nih.gov/pubmed/32281055 http://dx.doi.org/10.1007/s40256-020-00406-0 |